Clinical Trials Browser

Phase 1/2 × Recruiting × tepotinib × Clear all

NCT05439993 2022-07-05

Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma

Phase 1/2 Recruiting

Gastrointestinal

Stomach Neoplasms